Clinical Trials Directory

Trials / Completed

CompletedNCT02395367

Prospective, Observational, Real-world Oral Malignant Tumors Study

A Prospective, Observational, Real-world Study Based on the Register System of Oral and Maxillofacial Malignant Tumors

Status
Completed
Phase
Study type
Observational
Enrollment
30,000 (estimated)
Sponsor
Beijing Stomatological Hospital, Capital Medical University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The aim of the study is to construct a register system of oral and maxillofacial malignant tumors based on a prospective, observational, real-world study in north Chinese population.

Detailed description

A register system of oral and maxillofacial malignant tumors based on a prospective, observational, real-world study in Chinese population was absent. The aim of the study is to construct a register system of oral and maxillofacial malignant tumors based on a prospective, observational, real-world study in Chinese population. The variables in the study include social informatics, etiology, and psychological and quality of life, coexistence disease, baseline clinicopathological data, postoperative complications, and long-term follow-up results. By released annual analysis report, the epidemiological features and prognostic factors of oral and maxillofacial malignant tumors in north Chinese population can be identified.

Conditions

Interventions

TypeNameDescription
PROCEDUREresectionThis is an observational study. And we are interested in observing the outcome of different treatment methods.
RADIATIONadjuvant radiotherapyThis is an observational study. And we are interested in observing the outcome of different treatment methods.
DRUGneoadjuvant chemotherapy or adjuvant chemotherapyThis is an observational study. And we are interested in observing the outcome of different treatment methods.

Timeline

Start date
2015-03-01
Primary completion
2025-03-01
Completion
2025-03-01
First posted
2015-03-23
Last updated
2025-03-07

Locations

7 sites across 1 country: China

Source: ClinicalTrials.gov record NCT02395367. Inclusion in this directory is not an endorsement.